Concepedia

Eirini Bournazou

EB

Statistics

Publications

5

Citations

796

H-Index

5

Active since

2011

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

New York University

AstraZeneca (United States)

Roche (Switzerland)

Eirini Bournazou is an author at Memorial Sloan Kettering Cancer Center specializing in molecular oncology, medicine, and oncology.

Publications per year

2011–2021

5

Publications

5

The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis

Qing Chang, Eirini Bournazou, Pasquale Sansone et al. · Neoplasia · 2013 · 508 citations · Full text

, , +17

Antitumorigenic potential of STAT3 alternative splicing modulation

Francesca Zammarchi, Elisa de Stanchina, Eirini Bournazou et al. · Proceedings of the National Academy of Sciences · 2011 · 171 citations · Full text

, , +17

JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors

Sizhi Paul Gao, Qing Chang, Ninghui Mao et al. · Science Signaling · 2016 · 63 citations · Full text

, , +17

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

Michael Dickinson, Javier Briones, Alex F. Herrera et al. · Blood Advances · 2021 · 36 citations · Full text

, , +16

Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort

Eirini Bournazou, Jonathan Samuels, Hua Zhou et al. · International Journal of Molecular Sciences · 2019 · 18 citations · Full text

, , +17

1–5 of 5